Study to compare the safety and efficacy of 2 different doses of inhaled D8-THC to standard therapy with ondansetron in the prevention of acute nausea from moderately emetogenic chemotherapy.

Trial Profile

Study to compare the safety and efficacy of 2 different doses of inhaled D8-THC to standard therapy with ondansetron in the prevention of acute nausea from moderately emetogenic chemotherapy.

Suspended
Phase of Trial: Phase II

Latest Information Update: 02 May 2017

At a glance

  • Drugs Delta-8-THC (Primary) ; Ondansetron
  • Indications Nausea
  • Focus Therapeutic Use
  • Sponsors Rafa Laboratories
  • Most Recent Events

    • 09 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top